Arkolith/Insider Trading/FULC/Form 4/A

Gould Robert J

DirectorFulcrum Therapeutics, Inc. (FULC) · full profile →Form 4/A · filed Feb 4, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$163K
Net Open-Market Flow
-$163K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 2, 2026Sell(S)15K$10.87$163K470K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001193125-26-037606) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML